SBH
EXAS

Segall Bryant & Hamill’s Exact Sciences EXAS Stock Holding History

Segall Bryant & Hamill’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,315
Closed -$311K – 573
2023
Q2 		$311K Buy
3,315
+150
+5% +$11.7K ﹤0.01% 636
2023
Q1 		$214K Buy
+3,165
New +$203K ﹤0.01% 689
2022
Q2 		– Sell
-3,365
Closed -$235K – 730
2022
Q1 		$235K Hold
3,365
– – ﹤0.01% 711
2021
Q4 		$262K Sell
3,365
-278
-8% -$24.5K ﹤0.01% 568
2021
Q3 		$348K Sell
3,643
-70
-2% -$7.39K ﹤0.01% 676
2021
Q2 		$462K Sell
3,713
-303
-8% -$36.2K ﹤0.01% 627
2021
Q1 		$530K Sell
4,016
-302
-7% -$41.3K 0.01% 640
2020
Q4 		$572K Sell
4,318
-490
-10% -$59.3K 0.01% 553
2020
Q3 		$490K Buy
+4,808
New +$415K 0.01% 549

Other funds holding EXAS

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Segall Bryant & Hamill's EXAS Position: Q3 2023 in Review

Segall Bryant & Hamill sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 3,315 shares — an estimated $311K sold.

Segall Bryant & Hamill first reported a position in EXAS in Q3 2020 and held it in 9 quarters. The position peaked at $572K in Q4 2020. 624 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

  • Segall Bryant & Hamill reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
  • Segall Bryant & Hamill sold 3,315 Exact Sciences shares in Q3 2023, an estimated $311K.
  • Segall Bryant & Hamill first reported a position in Exact Sciences in Q3 2020 and held it in 9 quarters.
  • Segall Bryant & Hamill's Exact Sciences position peaked at $572K in Q4 2020.
  • 624 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on Segall Bryant & Hamill's 13F filing for Q3 2023, filed 9 Nov 2023.